Clinical Trials Sponsored by Sysmex America, Inc.

Total 1432 results

American Regent, Inc.

Completed

Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)

Restless Legs Syndrome (RLS)
American Regent, Inc.

Completed

Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients

Anemia

United States
American Regent, Inc.

Completed

Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments

Restless Legs Syndrome
American Regent, Inc.

Completed

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia

Anemia

United States
American Regent, Inc.

Withdrawn

Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum) (ASSURED)

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Taxoprexin® Treatment for Advanced Eye Melanoma

Metastatic Melanoma

United States
American Regent, Inc.

Completed

Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures

Pain

United States
American Regent, Inc.

Completed

Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia

Anemia

United States
Merz North America, Inc.
Ulthera, Inc

Completed

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

Décolleté Wrinkles

United States
Ulthera, Inc

Terminated

Simulines Non-Inferiority Pivotal Study

Skin Laxity

United States
Merz North America, Inc.
Ulthera, Inc

Completed

Study of the Cabochon System for Improvement in the Appearance of Cellulite

Gynoid Lipodystrophy

United States
Ulthera, Inc

Completed

A Retrospective Study to Evaluate the Effectiveness of the Ulthera System

Wrinkles | Skin Laxity

United States
Ulthera, Inc

Completed

Ulthera® System for Treating Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

United States
Ulthera, Inc

Completed

Reducing Wrinkles Around the Eyes Using the Ulthera® System

Periorbital Wrinkles

United States
Ulthera, Inc

Completed

Treatment of the Face and Neck With Lower Ulthera System Energy Settings

Skin Laxity

United States
Ulthera, Inc

Completed

Evaluation of the Ulthera® System for Treatment of the Brachia

Brachial Ptosis

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Lifting and Tightening Neck Skin in Patients

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Ulthera System for the Treatment of Rosacea

Erythematotelangiectatic Rosacea

Canada
Ulthera, Inc

Completed

Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis

Hyperhidrosis

United States
Ulthera, Inc

Terminated

Feasibility Study: Histological Characterization After Treatment With the Ulthera® System

Skin Laxity

United States
Mitsubishi Tanabe Pharma America Inc.

Active, not recruiting

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

EPP | XLP

United States, Germany, Japan, Spain, Italy, Sweden, Australia, Canada, Norway, United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis

Spain, Belgium, United States, United Kingdom, Poland, Canada, Germany, Italy
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States, Canada, Japan, France, Germany, Italy
Mitsubishi Tanabe Pharma America Inc.

Completed

Mass Balance Study With MT-7117 (MT-7117 MB)

Healthy Volunteer

United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

Vasomotor Symptoms (VMS)

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria

EPP | XLP

Spain, United States, Germany, Norway, Italy, Australia, Canada, Japan, Sweden, United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Mass Balance Study With MT-8554 (MT-8554 MB)

Healthy Volunteer

United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function

Mild and Moderate Hepatic Impairment

United States
Mayo Clinic
Olympus America, Inc.

Terminated

Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures.

Cancer | Obstruction | Stricture

United States
Toshiba America Medical Systems, Inc.

Completed

Clinical Image Evaluation for the DREX-KL80 Imaging System

Obtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation.

United States
Toshiba America Medical Systems, Inc.

Completed

Safety of the PET-512MC Transesophageal Transducer (TEE)

Transesophageal Transducer

United States
Mitsubishi Tanabe Pharma America Inc.

Recruiting

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP (INSPIRE)

Erythropoietic Protoporphyria (EPP) | X-Linked Protoporphyria (XLP)

United States, Spain, France, United Kingdom, Japan, Italy, Australia, Bulgaria, Czechia, Netherlands, Poland
Mitsubishi Tanabe Pharma America Inc.

Recruiting

Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Spinal Cord Injury

United States, Canada, Japan
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria

Erythropoietic Protoporphyria (EPP)

United States
Mitsubishi Tanabe Pharma America Inc.

Terminated

Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Korea, Republic of, Canada, Germany, Japan, Italy, Switzerland
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety and Efficacy Study of MT-2990 in Women With Endometriosis

Endometrial Related Pain

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

Healthy Subjects

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Canada, Japan, France, Germany, Italy
Mitsubishi Tanabe Pharma America Inc.

Completed

Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump Inhibitor (MT-7117 BA DDI)

Healthy Volunteer

Germany
Mitsubishi Tanabe Pharma America Inc.

Completed

Definitive QT Study With MT-8554 (MT-8554 DQT)

Healthy Volunteer

United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects

Healthy Subjects

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Renal Impairment | Normal Renal Function

Germany
Toshiba America Medical Systems, Inc.

Unknown

Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain

Confirm PCA-9000A PET/CT System is Effective for Its Intended Use

United States
Yale University
Apexigen America, Inc.

Recruiting

A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)

Renal Cell Carcinoma | Advanced Melanoma

United States
Mitsubishi Tanabe Pharma America Inc.

Terminated

Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Canada, Japan, Germany, Korea, Republic of, Switzerland
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury

Spinal Cord Injury

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

Menopause Hot Flashes

United States
Mitsubishi Tanabe Pharma America Inc.

Terminated

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects

Healthy

United Kingdom
Toshiba America Medical Systems, Inc.

Unknown

General Investigative MRI Protocol

Cardiac | Neck | Abdominal | Pelvis | Lumbar | Multiple MRI Exams, Including

United States

Clinical Trials Sponsored by Sysmex America, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations